TGen-HonorHealth study: High rate of tumor shrinkage among pancreatic cancer patients
SCOTTSDALE, Ariz. - April 25, 2017 - Adding cisplatin to the standard gemcitabine/nab-paclitaxel drug treatment provided a very high rate of tumor shrinkage for patients...






